| Study Title
* |
|
| Status * |
|
| Sponsor * |
|
| Protocol Number * |
|
| Sponsor Reference * |
|
| Drug Name |
|
| Drug Brand Name |
|
| Primary Sponsor Operating
Location * |
|
| Sponsor Contact
Information * |
| |
Current Contact
Info:
2 Tesseneer Dr. , Highland Heights, KY
41076
| |
| Therapeutic Area |
|
| Phase |
|
| PPD Global Central Labs
Location * |
|
| Business Development
Representative * |
|
| Bids and Contracts # |
|
| Expected Number of
Sites |
10
|
| Expected Number of Patients
Screened |
115 |
Expected Number of
Patients
Enrolled/Randomized |
65 |
| Expected Number of Patients
Completed |
30 |
| Study Population |
| Edit...
|
Current
Populations:
Geriatric, Min:65,
Max:90
Female Only, Min:n/a,
Max:n/a
| |
| Estimated Number of Patients Per
Country |
Edit...
|
